6 Recruiting Trials

Clinical Trials
for Multiple Sclerosis in Connecticut

6 clinical trials for Multiple Sclerosis are currently recruiting participants at study sites in Connecticut. Study-related care is provided at no cost.

6
Recruiting trials
8
Study sites
5
Cities
2
Industry-sponsored

Multiple Sclerosis clinical trials in Connecticut: what to expect

Multiple sclerosis trials divide into relapsing and progressive forms. Relapsing MS studies test new oral and infused disease-modifying therapies, usually against an approved medicine rather than a placebo. Progressive MS has fewer approved options, so trials there test drugs meant to slow disability, protect nerves or repair myelin, and often do use a placebo. Alongside these are trials of rehabilitation, exercise, diet, fatigue and bladder treatments, and studies that simply follow people over time with MRI and blood tests.

In Connecticut, recruiting multiple sclerosis studies are concentrated in New Haven, North Haven, Farmington and Hartford, with sites in 1 other city. 2 of the 6 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who multiple sclerosis trials usually look for

Listings state the type of MS, an age range (commonly 18 to 55 for relapsing trials, up to 65 for progressive) and a disability score range measured by the study neurologist. Relapsing trials usually want a relapse or new MRI activity in the past one to two years. Drug trials require a washout from your current therapy, which varies from weeks to months by drug and is managed by the site. Symptom and rehabilitation trials let you stay on your treatment.

What taking part involves

Screening includes a neurological exam, blood work and an MRI. Drug trials then run one to three years with visits every one to three months, an MRI every six to twelve months and a relapse assessment whenever symptoms change. Relapses are treated as normal. The study drug, scans and visits are free, and an extension usually lets everyone continue the active treatment afterwards. Rehabilitation trials involve sessions over eight to twenty-four weeks with walking, hand and cognition tests.

Questions worth asking the study team

What the comparison treatment is; how the washout from your current therapy is handled and how long it lasts; how many MRIs are needed; whether there is an extension; and what happens if you relapse during the study.

Showing 6 of 6 recruiting Multiple Sclerosis trials in Connecticut

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
N/A Birmingham, Alabama +4 sites NCT06433752
This trial is looking for people with a confirmed diagnosis of relapsing multiple sclerosis who are starting treatment with BRIUMVI®. Participants will receive the medication and share their experiences and results during the study.
Recruiting
Identifying and Characterizing Preclinical MS
N/A North Haven, Connecticut NCT05787795
This trial is looking for people who may be at risk of developing multiple sclerosis. Participants will help researchers identify factors that might indicate someone is likely to get the disease before any symptoms appear.
Recruiting
Intestinal Immunity in Neurologic Disease
N/A North Haven, Connecticut NCT06329453
This trial is looking for adults who may be experiencing sleep or movement disorders related to their nervous system. Participants will undergo a colonoscopy for research purposes to help understand immune cells in the gut.
Recruiting
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1 New Haven, Connecticut +4 sites NCT03816345
This trial is looking for adults with advanced cancers who also have autoimmune disorders. Participants will receive treatments that may include the drug nivolumab and possibly others to see how well they work together.
Recruiting
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
PHASE1 New Haven, Connecticut NCT06999434
This trial is looking for people between 18 and 90 years old. If you are in good health and understand what the study involves, you may be able to participate.
Recruiting
Neurologic Stem Cell Treatment Study
NA Westport, Connecticut +2 sites NCT02795052
This trial is looking for adults with certain neurologic conditions who have not improved with standard treatments. Participants will undergo a procedure involving their own stem cells to see if it helps with their symptoms.
Recruiting

Where the Multiple Sclerosis studies are in Connecticut

  • MD Stem Cells, Westport1 trial
  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven1 trial
  • TG Therapeutics Investigational Trial Site, Farmington1 trial
  • TG Therapeutics Investigational Trial Site, Hartford1 trial
  • Yale MS Clinic, North Haven1 trial
  • Yale University, New Haven1 trial

Counts are recruiting studies listing at least one site in Connecticut, from ClinicalTrials.gov, refreshed every two days.

Multiple Sclerosis clinical trials in Connecticut: common questions

How many Multiple Sclerosis clinical trials are recruiting in Connecticut?
TrialFinder currently lists 6 recruiting Multiple Sclerosis clinical trials with study sites in Connecticut. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Multiple Sclerosis clinical trials located in Connecticut?
Study sites for the Multiple Sclerosis trials listed on this page include North Haven, New Haven, Westport. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Multiple Sclerosis clinical trial in Connecticut?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Multiple Sclerosis trials in Connecticut also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Multiple Sclerosis clinical trial in Connecticut?
Each study sets its own criteria based on age, Multiple Sclerosis diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Will I get a placebo instead of MS treatment?
In relapsing MS almost never: trials compare the new drug with an approved medicine, so everyone is treated. Progressive MS trials more often use a placebo because fewer approved treatments exist, and an extension usually follows.
Do I need to stop my current MS medicine to join?
For a drug trial, yes, after a washout that depends on your current medicine and is supervised by the study neurologist. Trials of rehabilitation, diet or symptom treatments let you continue it.
What is an EDSS score?
The Expanded Disability Status Scale, a 0 to 10 score a neurologist assigns from an exam, mostly based on walking. Trials set a range, and the study neurologist scores you at screening; you do not need to know it in advance.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Multiple Sclerosis trials near you in Connecticut.

Get Matched — Free
No insurance required

MS trials investigate disease-modifying therapies, remyelination strategies, stem-cell transplants, and neuroprotective agents for relapsing and progressive forms of MS.

All Multiple Sclerosis trials →